Skip to content

Attention Bias Modification Treatment for Major Depressive Disorder in Adolescents

Attention Bias Modification Treatment for Major Depressive Disorder in Adolescents: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02078258
Enrollment
45
Registered
2014-03-05
Start date
2012-09-30
Completion date
2015-07-31
Last updated
2019-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder, Single Episode, Unspecified

Keywords

depression,adolescent,attention bias,modification

Brief summary

In this study, we test whether a two-week 8-session neutral attention bias modification (ABM) training and a two-week 4-session positive ABM could reduce depressive symptoms relative to placebo controls in adolescents with major depressive disorder at posttraining and follow-ups during one year.

Detailed description

Depression is a common health problem in adolescents. Negative attentional bias has been theorized to play a critical role in the onset and maintenance of depression, suggesting that reduction of such biases may treat symptoms of depression. Recent studies have shown that attention bias modification(ABM) training could reduce depressive symptoms in both dysphoria and previously depressed adult patients.To test the effectiveness of ABM training on the treatment of depressive symptoms in depressed adolescents, we designed a randomized, double-blind, placebo controlled trial in adolescents with major depressive disorder(MDD).

Interventions

BEHAVIORALABMT

During a two-week period, 8 sessions of a modified dot probe task for attentional bias modification training (ABMT) condition, 8 sessions of a classic dot probe task for placebo training (PT) condition.

Sponsors

Hunan Normal University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
11 Years to 19 Years
Healthy volunteers
No

Inclusion criteria

* Meet the major depression disorder's criteria

Exclusion criteria

* bipolar disorder, schizophrenia or organic mental disorder; * any concurrent psychotherapy; * any concurrent psychotropic medication.

Design outcomes

Primary

MeasureTime frameDescription
Changes in depressive symptom numberbaseline, 7-week, 6-month follow-upDepressive symptom accounts measured by Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children.
Changes in depressive severitybaseline, 7-week, 6-month follow-updepressive severity measured by the construct interview of the Schedule for Affective Disorders and Schizophrenia for School-Age Children(K-SADS)

Secondary

MeasureTime frameDescription
Change of Self-report symptomsbaseline, 7-week, 6-, 12-month follow-upsymptoms measured by the Center for Epidemiological Studies Depression Scale (CES-D), State-Trait Anxiety Inventory-Trait(STAI-T),Rumination Response Style(RRS),Suicidal Ideation Questionnaire(SIQ)
Diagnostic status of major depressive disorderbaseline, 7-week, 6-month follow-upAssessed by the diagnostic interview of the Schedule for Affective Disorders and Schizophrenia for School-Age Children

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026